HLA-C and neoplasm: To investigate if individual tumors may be better or less able to evade the patient’s immune system, we evaluated neo-antigen binding predictions between somatic mutations in each patient’s tumor and his or her own MHC alleles, as compared against the entire cohort in both trial and available archival specimens.